Quantbot Technologies LP Lexicon Pharmaceuticals, Inc. Transaction History

Quantbot Technologies LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$1.31 - $2.69 $4,748 - $9,751	-3,625 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$4.12 - $5.87 $100,186 - $142,740	-24,317 Reduced 87.03%	3,625 $16,000
Q1 2021 May 14, 2021	BUY	$3.45 - $9.09 $96,399 - $253,992	27,942 New	27,942 $164,000
Q1 2020 May 13, 2020	SELL	$1.8 - $4.28 $62,956 - $149,697	-34,976 Closed	0 $0
Q4 2019 Feb 10, 2020	BUY	$3.16 - $5.15 $110,524 - $180,126	34,976 New	34,976 $145,000
Q4 2018 Feb 13, 2019	SELL	$6.15 - $10.51 $52,951 - $90,491	-8,610 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$10.32 - $13.06 $88,855 - $112,446	8,610 New	8,610 $91,000

141

238M

459K

133K

Ticker LXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 188,726,000
Market Cap $153M
Description
Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.